Overview

A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

Status:
RECRUITING
Trial end date:
2025-10-22
Target enrollment:
Participant gender:
Summary
To investigate the relative bioavailability of two different vicadrostat/empagliflozin combinations. Additionally, the trial investigates the effect of food on the pharmacokinetics of the vicadrostat/empagliflozin.
Phase:
PHASE1
Details
Lead Sponsor:
Boehringer Ingelheim